
Spectrum Pharmaceuticals
(NASDAQ) SPPI
Spectrum Pharmaceuticals Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$25.77M
Net Income (TTM)
$65.06M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
SPPI News
SPPI: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Spectrum Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
86
CEO
Thomas J. Riga
Website
www.sppirx.comHeadquarters
Boston, MA 02110, US
SPPI Financials
Key Financial Metrics (TTM)
Gross Margin
82%
Operating Margin
-7%
Net Income Margin
-8%
Return on Equity
-2%
Return on Capital
-1%
Return on Assets
-76%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$8.32M
Operating Income
$72.70M
EBITDA
$77.06M
Operating Cash Flow
$96.99M
Capital Expenditure
$273.00K
Free Cash Flow
$97.26M
Cash & ST Invst.
$75.10M
Total Debt
$29.43M
Spectrum Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$15.62M
N/A
Gross Profit
$14.55M
N/A
Gross Margin
93.19%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
86
N/A
Net Income
$5.14M
+66.6%
EBITDA
$4.06M
+73.4%
Quarterly Fundamentals
Net Cash
$27.30M
-69.1%
Accounts Receivable
$33.64M
+5164.2%
Inventory
$12.86M
N/A
Long Term Debt
$28.84M
N/A
Short Term Debt
$771.00K
-23.0%
Return on Assets
-75.58%
N/A
Return on Invested Capital
-1.20%
N/A
Free Cash Flow
$21.55M
+29.0%
Operating Cash Flow
$21.44M
+29.2%







